Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | CCR6 | P51684 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | POLA1 | P09884 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.33 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | MMP2 | P08253 | 1/20 | 0.32 |
| ▸ | ANPEP | P15144 | 1/20 | 0.32 |
| ▸ | ELANE | P08246 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2690897 | 1.00 | HTT (0.35) | HTTCCR6ALDH1A1KMT2AATM | |
| SCHEMBL2690901 | 1.00 | HTT (0.35) | HTTCCR6ALDH1A1KMT2AATM | |
| SCHEMBL27811564 | 0.90 | ALDH1A1 (0.35) | HTTCCR6ALDH1A1KMT2AATM | |
| SCHEMBL10692865 | 0.90 | PPM1B (0.35) | HTTCCR6ALDH1A1KMT2AATM | |
| SCHEMBL1261691 | 0.90 | PPM1B (0.35) | HTTCCR6ALDH1A1KMT2AATM | |
| SCHEMBL10329694 | 0.90 | PPM1B (0.35) | HTTCCR6ALDH1A1KMT2AATM | |
| SCHEMBL11134886 | 0.88 | ATM (0.33) | HTTCCR6KMT2AATMCHRNB2 | |
| Hydrochloric Acid SCHEMBL11134893 | 0.88 | PPM1B (0.34) | HTTCCR6ALDH1A1KMT2AATM | |
| SCHEMBL12609929 | 0.86 | ATM (0.36) | HTTCCR6ALDH1A1ATMLMNA | |
| SCHEMBL11006784 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116332890-A | Preparation method of caronic anhydride | 北京博润天慧科技有限公司 | 2023-06-27 | — | — | CN | claimed |
| CN-116332890-A | Preparation method of caronic anhydride | 北京博润天慧科技有限公司 | 2023-06-27 | — | — | CN | disclosed |
| CN-116332890-A | Preparation method of caronic anhydride | 北京博润天慧科技有限公司 | 2023-06-27 | — | — | CN | disclosed |
| US-20230095750-A1 | FLOW CHEMISTRY SYNTHESIS OF ISOCYANATES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2023-03-30 | — | — | US | disclosed |
| EP-4073032-A1 | FLOW CHEMISTRY SYNTHESIS OF ISOCYANATES | The Regents of the University of California (US) | 2022-10-19 | — | — | EP | disclosed |
| WO-2021119606-A1 | FLOW CHEMISTRY SYNTHESIS OF ISOCYANATES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-06-17 | — | — | WO | disclosed |
| EP-1970369-B1 | METHOD FOR PRODUCING PURIFIED FORMYLCYCLOPROPANE COMPOUND AND INTERMEDIATE OF SUCH FORMYLCYCLOPROPANE COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2013-09-25 | — | — | EP | disclosed |
| CN-101326158-B | Process for preparing purified formylcyclopropane compounds and intermediates thereof | SUMITOMO CO LTD | 2013-04-17 | — | — | CN | disclosed |
| US-8168816-B2 | Method for producing purified formylcyclopropane compound and intermediate of such formylcyclopropane compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-05-01 | — | — | US | disclosed |
| US-20100305353-A1 | METHOD FOR PRODUCING PURIFIED FORMYLCYCLOPROPANE COMPOUND AND INTERMEDIATE OF SUCH FORMYLCYCLOPROPANE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-12-02 | — | — | US | disclosed |
| US-7598242-B2 | Compounds for the treatment of inflammatory disorders | SCHERING CORPORATION (US) | 2009-10-06 | — | — | US | disclosed |
| US-7598242-B2 | Compounds for the treatment of inflammatory disorders | SCHERING CORPORATION (US) | 2009-10-06 | — | — | US | disclosed |
| CN-101326158-A | Process for preparing purified formylcyclopropane compounds and intermediates thereof | SUMITOMO CHEMICAL CO (JP) | 2008-12-17 | — | — | CN | disclosed |
| EP-1970369-A1 | METHOD FOR PRODUCING PURIFIED FORMYLCYCLOPROPANE COMPOUND AND INTERMEDIATE OF SUCH FORMYLCYCLOPROPANE COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2008-09-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100305353-A1 | METHOD FOR PRODUCING PURIFIED FORMYLCYCLOPROPANE COMPOUND AND INTERMEDIATE OF SUCH FORMYLCYCLOPROPANE COMPOUND | FPR1, FPR2, DHPS | HTT 2139/4885CCR6 83/4885ALDH1A1 55/4885 |
| US-20230095750-A1 | FLOW CHEMISTRY SYNTHESIS OF ISOCYANATES | ALKBH3, ALKBH1, DHPS | HTT 245/4885CCR6 1435/4885ALDH1A1 552/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.